Inventor · disambiguated record
Michel Sournac
Also filed as: SOURNAC MICHEL
5 granted patents·4 pending applications·77 citations·filing 1991–2018
78Inventor score
Files withPF MEDICAMENT7
Top patents by PatentIndex Score
9 records- 0182US5132116ATablets of the hydrophilic matrix type based on salbutamol and a process for their preparationPF MEDICAMENT·Filed 1991·Granted Jul 21, 1992·53 cites·18 claims
- 0277US7018648B2Transdermal device for administering testosterone or one of the derivatives thereofPF MEDICAMENT·Filed 2000·Granted Mar 28, 2006·10 cites·26 claims
- 0365US10154969B2Transdermal device including porous microparticlesPF MEDICAMENT·Filed 2013·Granted Dec 18, 2018·1 cites·26 claims
- 0459US11173131B2Transdermal device including porous microparticlesPF MEDICAMENT·Filed 2018·Granted Nov 16, 2021·0 cites·18 claims
- 0554US2008317859A1Stabilization of Testosterone Within Transdermal DevicesPF MEDICAMENT·Filed 2006·Application pending·0 cites
- 0646US5334393ASustained-release tablet based on isosorbide 5-mononitrate and process for preparing itPF MEDICAMENT·Filed 1991·Granted Aug 2, 1994·13 cites·14 claims
- 0745US2010041703A1Rapid disintegration monolayer film for the oral administration of active substancesPF MEDICAMENT·Filed 2008·Application pending·0 cites
- 0836US2004022834A1Pharmaceutical oxan preparationFiled 2001·Application pending·0 cites
- 0935US2003082227A1Transdermal device comprising a reservoir and a matrix containing the same active principleFiled 2000·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michel Sournac files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →